| Target | Value |
|
Akt1
(Cell-free assay) | 8.4 μM |
|
Akt2
(Cell-free assay) | 8.9 μM |
Oridonin有效抑制各种癌细胞的增殖,包括来自前列腺癌 (LNCaP, DU145, PC3),乳腺癌(MCF-7, MDA-MB231),非小细胞肺癌 (NSCL) (NCI-H520, NCI-H460, NCI-H1299),急性早幼粒细胞白血病(NB4),以及胶质母细胞瘤(U118, U138)的细胞增殖,ED50s的范围为1.8 to 7.5 μ克/毫升。 Oridonin的抗肿瘤活性可能是由于它对NF-κB和MAPKs信号通路的抑制作用。
LD50:小鼠35-40毫克/千克。
| 中文名称 | 英文名称 | CAS号 | 化学式 | 分子量 |
|---|---|---|---|---|
| —— | (4aR,5S,6S,6aR,9S,11aS,11bS,14R)-5,6,14-trihydroxy-4,4-dimethyl-8-methylenedecahydro-1H-6,11b-(epoxymethano)-6a,9-methanocyclohepta[a]naphthalene-1,7(8H)-dione | 29288-74-2 | C20H26O6 | 362.423 |
| 冬凌草素 | lasiodin | 28957-08-6 | C22H30O7 | 406.476 |
| —— | CYD-6-84 | 1477507-19-9 | C21H26O7 | 390.433 |
| —— | (4aR,5S,6S,6aR,9S,11aS,11bS,14R)-5,6,14-trihydroxy-4,4-dimethyl-8-methylene-4,4a,5,6,9,10,11,11a-octahydro-1H-6,11b-(epoxymethano)-6a,9-methanocyclohepta[a]naphthalene-1,7(8H)-dione | 133082-30-1 | C20H24O6 | 360.407 |
| —— | (4aS,5S,6S,6aR,9S,11aS,11bR,14R)-5,6,14-trihydroxy-4,4-dimethyl-8-methylene-4,4a,5,6,9,10,11,11a-octahydro-3H-6,11b-(epoxymethano)-6a,9-methanocyclohepta[a]naphthalene-3,7(8H)-dion | 1477507-23-5 | C20H24O6 | 360.407 |
| —— | [(1S,2S,5S,8R,9S,10S,11R,15S,18R)-9,10,15-trihydroxy-12,12-dimethyl-6-methylidene-7-oxo-17-oxapentacyclo[7.6.2.15,8.01,11.02,8]octadecan-18-yl] octanoate | —— | C28H42O7 | 490.637 |
| —— | [(1S,2S,5S,8R,9S,10S,11R,15S,18R)-9,10,15-trihydroxy-12,12-dimethyl-6-methylidene-7-oxo-17-oxapentacyclo[7.6.2.15,8.01,11.02,8]octadecan-18-yl] cyclohexanecarboxylate | —— | C27H38O7 | 474.595 |
| —— | [(1S,2S,5S,8R,9S,10S,11R,15S,18R)-9,10,15-trihydroxy-12,12-dimethyl-6-methylidene-7-oxo-17-oxapentacyclo[7.6.2.15,8.01,11.02,8]octadecan-18-yl] adamantane-1-carboxylate | —— | C31H42O7 | 526.67 |
| —— | [(1S,2S,5S,8R,9S,10S,11R,18R)-9,10-dihydroxy-12,12-dimethyl-6-methylidene-7,15-dioxo-17-oxapentacyclo[7.6.2.15,8.01,11.02,8]octadecan-18-yl] cyclohexanecarboxylate | —— | C27H36O7 | 472.579 |
| —— | ent-1α,6β-dihydroxy-7,14-isopropylideneketal-15-oxo-7,20-epoxy-16-kaurene | 331282-94-1 | C23H32O6 | 404.503 |
| —— | CYD-5-29 | 133082-35-6 | C23H30O6 | 402.488 |
| —— | ent-1α-O-acetyl-6β-hydroxy-7,14-isopropylidene ketal-15-oxo-7,20-epoxy-16-kaurene | 331282-95-2 | C25H34O7 | 446.541 |
| —— | ent-1β,2β-epoxy-6β-hydroxy-7,14-isopropylideneketal-15-oxo-7,20-epoxy-16-kaurene | 1446495-04-0 | C23H30O6 | 402.488 |
| —— | oridonin | —— | C20H30O6 | 366.455 |
| —— | (3S,3aR,3a1R,6aR,7S,7aR,11aR,11bS)-7-hydroxy-5,5,8,8-tetramethyl-15-methylene-2,3,3a,7,7a,8,9,11b-octahydro-1H-6a,11a-(epoxymethano)-3,3a1-ethanophenanthro[1,10-de][1,3]dioxin-14-one | 1446494-90-1 | C23H30O5 | 386.488 |
| —— | (3S,3aR,3a1R,6aR,7S,7aR,11aS,11bS,Z)-7-hydroxy-10-(hydroxymethylene)-5,5,8,8-tetramethyl-15-methyleneoctahydro-1H-6a,11a-(epoxymethano)-3,3a1-ethanophenanthro[1,10-de][1,3]dioxine-11,14(2H)-dione | 1477507-17-7 | C24H30O7 | 430.498 |
| —— | (3S,3aR,3a1R,6aR,7S,7aS,9S,11aR,11bS)-7,9-dihydroxy-5,5,8,8-tetramethyl-15-methylene-2,3,3a,7,7a,8,9,11b-octahydro-1H-6a,11a-(epoxymethano)-3,3a1-ethanophenanthro[1,10-de][1,3]dioxin-14-one | 1446494-91-2 | C23H30O6 | 402.488 |
| —— | (1S,4aR,5S,6S,6aR,9S,11aS,11bS,14R)-1,5,6-trihydroxy-4,4-dimethyl-8-methylene-7-oxododecahydro-1H-6,11b-(epoxymethano)-6a,9-methanocyclohepta[a]naphthalen-14-yl (E)-3-(4-methoxyphenyl)acrylate | —— | C30H36O8 | 524.611 |
| —— | (3S,3aR,3a1R,6aR,7S,7aR,11aS,11bS)-7-hydroxy-5,5,8,8-tetramethyl-15-methylene-3,3a,7,7a,8,11b-hexahydro-1H-6a,11a-(epoxymethano)-3,3a1-ethanophenanthro[1,10-de][1,3]dioxine-11,14(2H)-dione | 133082-36-7 | C23H28O6 | 400.472 |
| —— | (3S,3aR,3a1R,6aR,7S,7aS,11aR,11bS)-7-hydroxy-5,5,8,8-tetramethyl-15-methylene-3,3a,7,7a,8,11b-hexahydro-1H-6a,11a-(epoxymethano)-3,3a1-ethanophenanthro[1,10-de][1,3]dioxine-9,14(2H)-dione | 1477507-22-4 | C23H28O6 | 400.472 |